Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis
- 29 October 2022
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 21 (2) , 314.e1-314.e7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Bladder Cancer Survival of Men Receiving 5α-Reductase InhibitorsJournal of Urology, 2018
- Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase InhibitorJournal of Urology, 2017
- Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening StudyEuropean Urology, 2016
- Androgen deprivation therapy prevents bladder cancer recurrenceOncotarget, 2014
- Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transitionAndrologia, 2013
- Epidermal growth factor enhances androgen receptor-mediated bladder cancer progression and invasion via potentiation of AR transactivationOncology Reports, 2013
- Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptorInternational Journal of Oncology, 2012
- Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cellsEndocrine-Related Cancer, 2011
- Androgen Receptor Is a Potential Therapeutic Target for Bladder CancerUrology, 2010
- BACILLUS CALMETTE-GUERIN VERSUS CHEMOTHERAPY FOR THE INTRAVESICAL TREATMENT OF PATIENTS WITH CARCINOMA IN SITU OF THE BLADDER: A META-ANALYSIS OF THE PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALSJournal of Urology, 2005